SCHEMBL30277946

SCHEMBL30277946

CC(C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)CCC(=O)O)[C@@H](C)O)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)NCC(=O)O)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ CALCR P30988 4/20 0.60
▸ CALCRL Q16602 5/20 0.58
▸ EP300 Q09472 1/20 0.56
▸ HIF1A Q16665 1/20 0.56
▸ EPHA2 P29317 2/20 0.54
▸ TFPI P10646 2/20 0.54
▸ KEAP1 Q14145 1/20 0.53
▸ GLP1R P43220 3/20 0.53
▸ GIPR P48546 3/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31000879 0.97 CALCRL (0.60) CALCRCALCRLEP300HIF1AKEAP1
SCHEMBL30277935 0.95 CALCR (0.61) CALCRCALCRLEP300HIF1AGLP1R
SCHEMBL31000872 0.94 CALCR (0.60) CALCREP300HIF1AKEAP1GLP1R
SCHEMBL31000906 0.93 CALCR (0.59) CALCRCALCRLEP300HIF1AKEAP1
SCHEMBL30726592 0.93 CALCR (0.62) CALCRCALCRLEP300HIF1A
SCHEMBL30607374 0.91 CALCR (0.58) CALCREP300HIF1A
SCHEMBL30429242 0.89 CALCR (0.63) CALCREP300HIF1A
SCHEMBL31182741 0.88 CALCR (0.62) CALCREP300HIF1ATFPI
SCHEMBL30495657 0.88 EPHA2 (0.63) CALCREP300HIF1AEPHA2TFPI
SCHEMBL30429340 0.88 OPRM1 (0.60) CALCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240352445-A1 HUMANIZATION, AFFINITY MATURATION, AND OPTIMIZATION METHODS FOR PROTEINS AND ANTIBODIES ABWIZ BIO, INC. 2024-10-24 — — US disclosed
WO-2023019019-A2 HUMANIZATION, AFFINITY MATURATION, AND OPTIMIZATION METHODS FOR PROTEINS AND ANTIBODIES ABWIZ BIO, INC. (US) 2023-02-16 — — WO disclosed
Send feedback